Access
To read this story in full you will need to login or make a payment (see right).
News
Nature Medicine 13, 1008 - 1009 (2007)
Published online: 31 August 2007 | doi:10.1038/nm0907-1008
Therapy on trial
Virginia Hughes1
- Virginia Hughes is a freelance writer based in New York.
Abstract
The death of a participant in a gene therapy trial has thrown the entire field into question–as it did once before in 1999. Can the field survive this second setback? Virginia Hughes investigates.
Three weeks after receiving a second knee injection of an experimental gene therapy to treat her rheumatoid arthritis, 36-year-old Jolee Mohr lay unconscious at the University of Chicago Medical Center, breathing through a ventilator while her liver gave out. On 24 July, her family opted to remove life support.
To read this story in full you will need to login or make a payment (see right).
